Henrik Zetterberg

Zetterberg with the [[Detroit Red Wings]] in February 2012 Henrik Zetterberg (; born 9 October 1980) is a Swedish former professional ice hockey forward. He played his entire National Hockey League career, from 2002 to 2018, with the Detroit Red Wings of the National Hockey League.

Bursting onto the scene as a rookie in the 2002–03 NHL season, Zetterberg would finish 2nd overall in votes for the Calder Memorial Trophy as the League's top rookie. Along with winning the Stanley Cup in 2008, Zetterberg won the Conn Smythe Trophy as the Most Valuable Player of the 2008 Stanley Cup playoffs. He won gold medals in the 2006 Ice Hockey World Championships and 2006 Winter Olympics, as part of the first team to ever win both tournaments in the same year, also making him a member of the Triple Gold Club. Provided by Wikipedia
Showing 1 - 20 results of 375 for search 'Henrik Zetterberg', query time: 0.07s Refine Results
  1. 1
    The Cerebrospinal Fluid in Multiple Sclerosis

    The Cerebrospinal Fluid in Multiple Sclerosis by Florian Deisenhammer, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Brit Fitzner, Uwe K. Zettl

    Published 2019-04-01
    Get full text
    Article
  2. 2
    Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies

    Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies by Andreas Bjorefeldt, Andreas Bjorefeldt, Sebastian Illes, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Eric Hanse

    Published 2018-02-01
    Get full text
    Article
  3. 3
    High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis

    High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis by Igal Rosenstein, Markus Axelsson, Lenka Novakova, Sofia Rasch, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Jan Lycke

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Perioperative brain injury marker concentrations in neonatal open-heart surgery: a prospective observational study

    Perioperative brain injury marker concentrations in neonatal open-heart surgery: a prospective observational study by Åsa Jungner, Finn Lennartsson, Isabella Björkman-Burtscher, Isabella Björkman-Burtscher, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, David Ley

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis

    Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis by Igal Rosenstein, Sofia Rasch, Markus Axelsson, Lenka Novakova, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Jan Lycke

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis?

    Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis? by Henrik Zetterberg

    Published 2020-07-01
    Get full text
    Article
  7. 7
    A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease

    A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease by Xiaofang Zhong, Jingxin Wang, Cynthia Carlsson, Ozioma Okonkwo, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Lingjun Li, Lingjun Li

    Published 2019-01-01
    Get full text
    Article
  8. 8
    Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease

    Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease by Tina E. Brinkley, Iris Leng, Thomas C. Register, Bryan J. Neth, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Kaj Blennow, Kaj Blennow, Suzanne Craft

    Published 2022-06-01
    Get full text
    Article
  9. 9
    Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study

    Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study by Anja Fernqvist, Anja Fernqvist, Eirini Alexiou, Eirini Alexiou, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Katarina Howner, Katarina Howner, Thomas Nilsson, Thomas Nilsson, Peter Andiné, Peter Andiné, Peter Andiné

    Published 2023-05-01
    Get full text
    Article
  10. 10
    Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 by Thomas K. Karikari, Augustina Charway-Felli, Kina Höglund, Kina Höglund, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg

    Published 2018-03-01
    Get full text
    Article
  11. 11
    The Shape of Things to Come. An Interview with Henrik Zetterberg-Nielsen

    The Shape of Things to Come. An Interview with Henrik Zetterberg-Nielsen by Henrik Zetterberg-Nielsen

    Published 2022-07-01
    Get full text
    Article
  12. 12
    A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis

    A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis by Sofia Sandgren, Sofia Sandgren, Lenka Novakova, Lenka Novakova, Anna Nordin, Anna Nordin, Markus Axelsson, Markus Axelsson, Clas Malmeström, Clas Malmeström, Clas Malmeström, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Jan Lycke, Jan Lycke

    Published 2023-09-01
    Get full text
    Article
  13. 13
    Editorial: Blood Biomarkers of Neurodegenerative Diseases

    Editorial: Blood Biomarkers of Neurodegenerative Diseases by Thomas K. Karikari, Thomas K. Karikari, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Kaj Blennow, Kaj Blennow

    Published 2022-06-01
    Get full text
    Article
  14. 14
    Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint

    Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint by Deborah O. T. Alawode, Deborah O. T. Alawode, Nick C. Fox, Nick C. Fox, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Amanda J. Heslegrave, Amanda J. Heslegrave

    Published 2022-04-01
    Get full text
    Article
  15. 15
    Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

    Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics by Henrik Zetterberg, Kaj Blennow

    Published 2021-02-01
    Get full text
    Article
  16. 16
    High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis

    High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis by Avadhesh Kumar Singh, Lenka Novakova, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Jan Lycke, Susanna L. Cardell

    Published 2017-03-01
    Get full text
    Article
  17. 17
    Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis

    Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis by Xiaobei Pan, Paul C. Donaghy, Gemma Roberts, Leonidas Chouliaras, John T. O’Brien, Alan J. Thomas, Amanda J. Heslegrave, Amanda J. Heslegrave, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Bernadette McGuinness, Anthony P. Passmore, Brian D. Green, Joseph P. M. Kane

    Published 2024-01-01
    Get full text
    Article
  18. 18
    Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults

    Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults by Grant L. Iverson, Grant L. Iverson, Grant L. Iverson, Mira Minkkinen, Justin E. Karr, Ksenia Berghem, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Kaj Blennow, Kaj Blennow, Jussi P. Posti, Jussi P. Posti, Teemu M. Luoto

    Published 2022-11-01
    Get full text
    Article
  19. 19
    Neurodegenerative dementias: screening for major threats to healthy longevity with blood biomarkers

    Neurodegenerative dementias: screening for major threats to healthy longevity with blood biomarkers by Henrik Zetterberg, Barbara B Bendlin

    Published 2021-02-01
    Get full text
    Article
  20. 20
    Blood-based molecular biomarkers for Alzheimer’s disease

    Blood-based molecular biomarkers for Alzheimer’s disease by Henrik Zetterberg, Samantha C. Burnham

    Published 2019-03-01
    Get full text
    Article

Search Tools: